David T. Howton, EVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 78,000 shares at $125.50 ($9.8M) on 2019-12-13, disclosed to the SEC on 2019-12-17.
Open-market sale of $9.8M SRPT by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |